113 related articles for article (PubMed ID: 21029691)
1. [Pro-apoptotic effect on osteosarcoma SOSP-9607 cells by human recombinant caspase-6 fusion protein].
Zhou BG; Qiu XC; Xu YM; Fan QY
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):497-500. PubMed ID: 21029691
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma.
Zhou BG; Liu MY; Qiu XC; Xu YM; Fan QY; Yang AG; Zhang Y; Xia H
Oncol Rep; 2013 Jan; 29(1):276-82. PubMed ID: 23135254
[TBL] [Abstract][Full Text] [Related]
3. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
4. Construction of the plasmid for expression of ETA-EGFP fusion protein under control of the cytomegalovirus promoter and its effects in HeLa cells.
Glinka EM; Andryushchenko AS; Sapozhnikov AM; Zatsepina OV
Plasmid; 2009 Sep; 62(2):119-27. PubMed ID: 19527753
[TBL] [Abstract][Full Text] [Related]
5. A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors.
Xu YM; Wang LF; Jia LT; Qiu XC; Zhao J; Yu CJ; Zhang R; Zhu F; Wang CJ; Jin BQ; Chen SY; Yang AG
J Immunol; 2004 Jul; 173(1):61-7. PubMed ID: 15210759
[TBL] [Abstract][Full Text] [Related]
6. [Construction and expression of recombinant antibody/granzyme B containing truncated translocating peptide].
Zhang L; Zhao J; Wang Z; Wen WH; Zhang YH; Wang CJ; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):434-6. PubMed ID: 15169648
[TBL] [Abstract][Full Text] [Related]
7. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
[TBL] [Abstract][Full Text] [Related]
8. A novel recombinant immuno-tBid with a furin site effectively suppresses the growth of HER2-positive osteosarcoma cells in vitro.
Shan LQ; Ma S; Qiu XC; Wang T; Yu SB; Ma BA; Zhou Y; Fan QY; Yang AG
Oncol Rep; 2011 Feb; 25(2):325-31. PubMed ID: 21152867
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of small interfering RNA targeting MDM2 on human osteosarcoma cells].
Lü JY; Gao ZL; Wang JC; Wu DK; Zhao DX; Zhang DD; Zhao YY
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):502-5. PubMed ID: 19062715
[TBL] [Abstract][Full Text] [Related]
10. scFv-mediated delivery of truncated BID suppresses HER2-positive osteosarcoma growth and metastasis.
Shan LQ; Qiu XC; Xu YM; Ji ZG; Yang TT; Chen X; Ma BA; Zhou Y; Fan QY; Yang AG
Cancer Biol Ther; 2008 Nov; 7(11):1717-22. PubMed ID: 18787415
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of human lung cancer cells and implanted tumors by adenovirus-mediated transfer of the PTEN gene.
Chen Z; Yang J
J Huazhong Univ Sci Technolog Med Sci; 2010 Apr; 30(2):149-54. PubMed ID: 20407863
[TBL] [Abstract][Full Text] [Related]
12. Selective proapoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2.
Yu CJ; Jia LT; Meng YL; Zhao J; Zhang Y; Qiu XC; Xu YM; Wen WH; Yao LB; Fan DM; Jin BQ; Chen SY; Yang AG
Gene Ther; 2006 Feb; 13(4):313-20. PubMed ID: 16267568
[TBL] [Abstract][Full Text] [Related]
13. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer.
Waldron NN; Kaufman DS; Oh S; Inde Z; Hexum MK; Ohlfest JR; Vallera DA
Mol Cancer Ther; 2011 Oct; 10(10):1829-38. PubMed ID: 21862685
[TBL] [Abstract][Full Text] [Related]
15. Biotechnological and gene therapeutic strategies in cancer treatment.
Wels W; Moritz D; Schmidt M; Jeschke M; Hynes NE; Groner B
Gene; 1995 Jun; 159(1):73-80. PubMed ID: 7607575
[TBL] [Abstract][Full Text] [Related]
16. [
Ma J; Chen SJ; Qin Y; Zhang YY; Sun XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):430-437. PubMed ID: 34018361
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma].
Wu Q; Yang SH; Ye SN; Wang RY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):409-13. PubMed ID: 15854533
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins.
Jeschke M; Wels W; Dengler W; Imber R; Stöcklin E; Groner B
Int J Cancer; 1995 Mar; 60(5):730-9. PubMed ID: 7860149
[TBL] [Abstract][Full Text] [Related]
20. [Construction of interleukin-18-PE38 fusion gene eukaryotic expression vector and its expression in the. chondrocyte].
Wu X; Zhang L; Qu Y; Li MY; Jiang ZH; Li H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):456-9. PubMed ID: 16078559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
